A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Science

• Publication date

  1994-10-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.7545954PMID 7545954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture.

  1994cited by this paper
• Familiality of cancer in Utah.

  1994cited by this paper
• Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

  1994cited by this paper
• A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1.

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1

  1994cited by this paper
• A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas.

  1994cited by this paper
• Genetic analysis of the BRCA1 region in a large breast/ovarian family: refinement of the minimal region containing BRCA1.

  1993cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Identification and preliminary characterization of a protein motif related to the zinc finger.

  1993cited by this paper
• Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA.

  1993cited by this paper
• Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion.

  1993cited by this paper
• Association between wild type and mutant APC gene products.

  1993cited by this paper
• THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21.

  1993cited by this paper
• A breast-ovarian cancer susceptibility gene maps to chromosome 17q21.

  1993cited by this paper
• Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.

  1993cited by this paper
• Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding

  1992cited by this paper
• Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

  1992cited by this paper
• Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.

  1992cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• Genetic analysis of breast cancer in the cancer and steroid hormone study.

  1991cited by this paper
• Incidence of cancer in 161 families affected by ataxia-telangiectasia.

  1991cited by this paper
• Direct selection: a method for the isolation of cDNAs encoded by large genomic regions.

  1991cited by this paper
• The association of age and familial risk in a case-control study of breast cancer.

  1990cited by this paper
• An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.

  1990cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Supercondensed structure of plasmid pBR322 DNA in an Escherichia coli DNA topoisomerase II mutant.

  1990cited by this paper
• Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene

  1988cited by this paper
• rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1.

  1988cited by this paper
• An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

  1987cited by this paper
• Clustered genes for human U2 RNA.

  1984cited by this paper
• Identification of common molecular subsequences.

  1981cited by this paper
• Malignant neoplasms in the families of patients with ataxia-telangiectasia.

  1976cited by this paper

• From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancer

  2026cites this paper
• New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication

  2026cites this paper
• Hereditary Endometrial Cancer: Lynch Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions—A Comprehensive Review with Clinical and Laboratory Guidelines

  2026cites this paper
• Consideration of inherited cancer risk on a continuum: An international and multidisciplinary perspective: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).

  2026cites this paper
• Depletion of BRCA1 Potentiates Progestin-Induced Cytoskeletal Changes in an Ovarian Cancer Cell Model

  2026cites this paper
• Disease- and gene-specific deep learning for pathogenicity prediction of rare missense variants in cancer predisposition genes.

  2026cites this paper
• Genetic Basis of Familial Cancer Risk: A Narrative Review

  2026cites this paper
• Influence of DNA copy number aberrations and changes in the expression level of homologous recombination genes on the survival of primary operable non-small cell lung cancer patients

  2026cites this paper
• Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

  2026cites this paper
• Metabolomic-driven prediction of the mutational status of healthy individuals with a family history of hereditary breast and ovarian cancer syndrome: the HRRmet study

  2026cites this paper
• A Real-Time, Programmable, and Multiplex Ligation Chain Reaction-MNAzyme Platform for Single-Nucleotide Variant Detection.

  2026cites this paper
• Frequency of Founder Mutations in BRCA1 and BRCA2 Genes in Hereditary Breast Cancers in Poland vs. Other Countries

  2026cites this paper
• A Comprehensive Bioinformatics Approach to Analysis of Variants: Variant Calling, Annotation, and Prioritization.

  2025cites this paper
• BRCA1 and BRCA2 mutations testing in prostate cancer: Detection in formalin fixed paraffin embedded (FFPE) and blood samples.

  2025cites this paper
• Repair of DNA double-strand breaks after low radiation doses in childhood cancer survivors and matched cancer-free individuals

  2025cites this paper
• BRCA1 deficiency leads to aberrant epithelial differentiation in the thymus

  2025cites this paper
• Circular RNAs as central regulators of metabolic reprogramming and immune responses in the breast cancer microenvironment: A comprehensive review.

  2025cites this paper
• Recessive Effect of GC-NPFFR2 rs137147462 on Somatic Cell Score (Mastitis Susceptibility) in Japanese Holsteins

  2025cites this paper
• Hereditary cancer syndromes linked to oxidative phosphorylation insufficiency

  2025cites this paper
• EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers

  2025cites this paper
• Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women

  2025cites this paper
• Synergistic Effects of Radiotherapy and PD‑1 Blockade in a Human‑Mimetic BRCAness Model of Triple-Negative Breast Cancer

  2025cites this paper
• Nanomaterial-Enhanced Electrochemical Biosensing of Breast Cancer Biomarkers: A Review of Innovations in Materials, Mechanisms, and Clinical Potential

  2025cites this paper
• Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees

  2025cites this paper
• Beyond repair: Expanding roles of BRCA1 in RNA processing and cancer.

  2025cites this paper
• Timely access to risk-reducing bilateral mastectomy: a systematic review of uptake, predictors, surgical waiting times and barriers

  2025cites this paper
• ENGAGING STUDENT INNOVATION: BENCH TO BEDSIDE AT THE UNIVERSITY OF UTAH

  2025cites this paper
• Human Cancers Derived from Either Genetic or Lifestyle Factors Are Initiated by Impaired Estrogen Signaling

  2025cites this paper
• Breast cancer mortality in Romania: trends, regional and rural–urban inequalities, and policy implications

  2025cites this paper
• New twist on BRCA1-mediated DNA recombination repair and tumor suppression.

  2025cites this paper
• [Family history of breast cancer - Genetic screening and risk-based surveillance].

  2025cites this paper
• Oncogénétique : les cancers héréditaires du sein

  2025cites this paper
• Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis

  2025cites this paper
• Screening of Germline BRCA1 and BRCA2 Variants in Nigerian Breast Cancer Patients

  2025cites this paper
• Exploring Urtica dioica L. as a Promising Alternative Therapy for Obesity-Related Breast Cancer: Insights from Molecular Mechanisms and Bioinformatic Analysis

  2025cites this paper
• Pilocytic astrocytoma with BARD1 mutation: oncogenic pathways via DNA damage repair mechanism and MAPK/BRAF.

  2025cites this paper
• Identification of BRCA1 Gene Mutation Variants in Clinical Samples without a Labeling Step─A Comparison of the Functionality and Sensitivity of SPR and SERS Sensors

  2025cites this paper
• Association of Gene Variant Type and Location with Breast Cancer Risk in the General Population.

  2025cites this paper
• Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA Variants

  2025cites this paper
• Oxidative Stress, Genetic Factors and Behavioral Responses to Chemical Exposure: Insights into Cancer Development in Zebrafish (Danio Rerio).

  2025cites this paper
• Complex Interplay Between Obesity and BRCA1/2‐Associated Breast Cancer: An Overview

  2025cites this paper
• Real-World Impact of a BRCA Testing Protocol in Portugal

  2025cites this paper
• From Expert Judgment to Structured Guidelines: A Brief History and Bright Future of DNA Variant Interpretation

  2025cites this paper
• Proteogenomic characterization of invasive breast tumors in young women

  2025cites this paper
• BRCA1 and BRCA2 gene expression: p53- and cell cycle-dependent repression requires RB and DREAM

  2025cites this paper
• Clinical Management in BRCA Carriers with Early Breast Cancer

  2025cites this paper
• Sparse vertex discriminant analysis: Variable selection for biomedical classification applications

  2025cites this paper
• Breast Cancer in Women with Moderate and High Penetrance Germline Pathogenic Variants in Breast Cancer Susceptibility Genes

  2025cites this paper
• Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications

  2025cites this paper
• A human supergene: BRCA1, CCDC200, and U2 snRNAs

  2025cites this paper
• A multi-representation deep-learning framework for accurate multicancer classification

  2025cites this paper
• HSP90 buffers deleterious genetic variations in BRCA1.

  2025cites this paper
• G protein-coupled receptor digital twins for precision and personalized medicine

  2025cites this paper
• Associations between Pathogenic Germline Variants in BRCA and Non-Breast/Non-Ovarian Cancer Types in the German Population

  2025cites this paper
• Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer

  2025cites this paper
• Computational studies on the functional and structural impact of pathogenic mutations in enzymes

  2025cites this paper
• High Mortality in the Male Breast Cancer Community: A Report on Its Drivers and a Demand for Change in Healthcare Policy

  2025cites this paper
• Prevalence of Novel and Recurrent Pathogenic Variants in BRCA Genes in a Cohort of Iranian Hereditary Breast Cancer Patients

  2025cites this paper
• Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon.

  2025cites this paper
• The art of war: using genetic insights to understand and harness radiation sensitivity in hematologic malignancies

  2025cites this paper
• The long road to unbiased estimates of pancreatic cancer incidence in the hereditary breast and ovarian cancer syndrome

  2025cites this paper
• Causative Genes of Homologous Recombination Deficiency (HRD)-Related Breast Cancer and Specific Strategies at Present

  2025cites this paper
• A Guide to Breast Cancer Research: An Introduction.

  2025cites this paper
• Cells-of-Origin of Breast Cancer and Intertumoral Heterogeneity.

  2025cites this paper
• No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing

  2025cites this paper
• In silico evaluation of missense SNPs in cancer-associated Cystatin A protein and their potential to disrupt Cathepsin B interaction

  2025cites this paper
• PALB2 germline pathogenic variants: frequency, clinical features, and functional analysis of c.3350+5G>A variant in 3987 Korean cancer patients

  2025cites this paper
• Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.

  2025cites this paper
• Mammalian Species-Specific Resistance to Mammary Cancer

  2025cites this paper
• Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

  2025cites this paper
• Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies

  2025cites this paper
• Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1 mRNA via IGF2BP2-mediated m6A modification

  2025cites this paper
• Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in cervical precancerous lesions.

  2025cites this paper
• BRCA1 is a molecular correlate of cell proliferation in human brain development and in Group 3 and 4 medulloblastoma

  2025cites this paper
• Twelve Years of Male Breast Cancer Experience at One Center

  2025cites this paper
• Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden

  2025cites this paper
• Double heterozygosity for BRCA1 and BRCA2 in breast cancer: considerations in surveillance and cancer risk management

  2025cites this paper
• Genetic determinants of proteomic aging

  2025cites this paper
• Stronger preference of human tumor suppressor protein BRCA1 for an open-planar Holliday junction: Insights from a combined spectroscopic and computational study.

  2025cites this paper
• BRCA1 influences whole-body metabolism in humanized mice.

  2025cites this paper
• BRCA1 and BRCA2 in DNA damage and replication stress response: Insights into their functions, mechanisms, and implications for cancer treatment.

  2025cites this paper
• Case Report: Biallelic BRCA1 pathogenic alterations in a Fanconi Anemia patient and clinical implications of variant location

  2025cites this paper
• Novel Shared Heritable Candidate Risk Loci of Breast and Endometrial Cancer—A Swedish Haplotype Genome-Wide Association Study

  2025cites this paper
• Exploring the Ligandability of 53BP1 through Fragment-Based Approaches.

  2025cites this paper
• Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations.

  2025cites this paper
• Update in the clinical utilization of chemoprevention for breast cancer: a narrative review

  2025cites this paper
• Inherited Susceptibility to Cancer: Past, Present and Future

  2025cites this paper
• Characterization and functional analysis of BRCA1 and BRCA2 variants in a cohort of 100 unselected patients undergoing germline screening

  2025cites this paper
• Current insights into breast and ovarian cancer risk: a contemporary review.

  2025cites this paper
• Prostate cancer germline variants with therapeutic implications.

  2025cites this paper
• Increasing pathogenic germline variant diagnosis rates in precision medicine: current best practices and future opportunities

  2025cites this paper
• Hotspots and future trends of male breast cancer: a global perspective

  2025cites this paper
• Redefining Risk, Biomarkers, and Precision Therapy for Hereditary Ovarian Cancer: A Review

  2025cites this paper
• Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration.

  2025cites this paper
• Exploring the Therapeutic Potential of BRCA1 and BRCA2 as Targets in Canine Oncology: A Comprehensive Review of Their Role in Cancer Development and Treatment

  2025cites this paper
• Surgical management of breast cancer: a review

  2025cites this paper
• NRF2 expression level and estrogen function in BRCA1-mutated breast cancer

  2025cites this paper
• Methylation differences between assisted reproductive technology-conceived and naturally conceived children near BRCA1 and NBR2

  2025cites this paper
• Germline Mutations as Cancer Drug Targets.

  2025cites this paper
• ZBTB6 promotes breast cancer progression by inhibiting ARHGAP6 transcription and modulating the STAT3 signaling pathway

  2025cites this paper